相关实验视频

Updated: Jun 5, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

含有迪苏尔菲拉姆的高分子纳米囊具有抗癌活性,用于癌症治疗

Nina Filipczak¹, Bharat Ashok Rajmalani¹, Janaina Artem Ataide²

¹Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.

International journal of pharmaceutics

|December 11, 2024

概括

迪苏尔菲拉姆 (DSF) 显示出癌症治疗的前景. 与免费的DSF相比,Polycaprolactone纳米囊增强了DSF的输送,改善了稳定性,并增加了抗瘤效果的两倍,减少了副作用.

科学领域:

药理学药理学是指药理学的学科.
纳米技术纳米技术
在瘤学瘤学.

背景情况:

酒精成药物迪苏尔菲拉姆 (DSF) 通过抑制癌细胞生长,转移和诱导亡,表现出抗癌性质.
DSF可以使癌细胞对化疗和辐射敏感,显示对乳腺癌,前列腺癌和质母细胞瘤的有效性.

研究的目的:

评估基于聚烯酸的纳米囊作为在癌症治疗中使用的DISULFIRAM (DSF) 的输送系统.
评估DSF装载纳米囊的稳定性,释放特征和治疗疗效.

主要方法:

聚烯酸纳米囊被合成以封装DSF,确保稳定的尺寸分布 (∼250nm) 和长期稳定性.
研究了纳米囊中DSF的释放动力学,并与自由的DSF相比对瘤细胞进行了细胞毒性评估.

主要成果:

纳米囊显示了持续和受控的DSF释放,解决了药物不稳定性.
与免费的DSF相比,装载DSF的纳米囊显示了针对特定瘤的细胞毒性增加了两倍.
增强的疗效归因于纳米囊的持续释放特征.

结论:

聚烯纳米囊在癌症治疗中代表了Disulfiram (DSF) 的一个有前途的输送系统.
这种纳米载体系统提高了DSF的治疗效果,并有可能减少副作用.
基于纳米囊的输送提供了一种策略,可以增强DSF等现有药物的抗癌潜力.

关键词:

癌症癌症癌症癌症迪苏尔菲拉姆 (Disulfiram) 是一种药物输送系统是药物输送系统.在纳米囊中.聚卡普罗拉克 (Polycaprolactone) 是一种多重的产物.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...